Institutional investors hold a majority ownership of A through the 88.38% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.3 Million shares of Agilent Technologies Inc
CITADEL ADVISORS LLC Bought 2.2 Million shares of Agilent Technologies Inc